We are live on ! Find out more
CELUW

Celularity Inc

Delisted

CELUW was delisted on the 17th of July, 2026.

19 hedge funds and large institutions have $438K invested in Celularity Inc in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.46% less ownership

Funds ownership: 5.07%4.61% (-0.46%)

5% less funds holding

Funds holding: 2019 (-1)

33% less capital invested

Capital invested by funds: $655K → $438K (-$217K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
7
Closed
3
Calls
$40K
Puts
Net Calls
+$40K
Net Calls Change
-$4K

CELUW Hedge Fund Activity: Q1 2023 in Review

19 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2023, worth a combined $438K — down 33% from $655K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CELUW and 2 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 1 added.

The largest buyer was Walleye Capital, adding an estimated $4.68K. The largest seller was RPO LLC, cutting an estimated $19.6K.

  • 19 institutional investors held Celularity Inc (CELUW) as of Q1 2023, down from 20 in Q4 2022.
  • Funds reported $438K of Celularity Inc stock for Q1 2023, down 33% quarter-over-quarter.
  • 2 funds opened new Celularity Inc positions in Q1 2023 and 3 closed out, a net change of -1 holder.
  • The largest Celularity Inc buyer in Q1 2023 was Walleye Capital, an estimated $4.68K added.
  • The largest Celularity Inc seller in Q1 2023 was RPO LLC, an estimated $19.6K sold.

Based on aggregated 13F filings for Q1 2023.